Therapeutic Asset Ratings

344 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ibrutinib Multiple Myeloma	Anne Louise Tølbøll Sørensen	P4	B (60)
Melphalan Hydrochloride For Multiple Myeloma	Peking University People's Hospital	P4	B (60)
Mitoxantrone Multiple Myeloma	Affiliated Hospital of Nantong University	P4	B (60)
Tocilizumab Multiple Myeloma	SCRI Development Innovations, LLC	P4	B (60)
Epirubicin Multiple Myeloma	Andrew Hantel, MD	P3	B (60)
Irinotecan Multiple Myeloma	OHSU Knight Cancer Institute	P3	B (60)
Phosphonic acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]- Multiple Myeloma	The Affiliated People's Hospital of Ningbo University	P3	B (60)
Plerixafor Multiple Myeloma	Thomas Jefferson University	P3	B (60)
Selinexor Multiple Myeloma	Natalie Callander	P3	B (60)
Venetoclax Multiple Myeloma	Oncotherapeutics	P3	B (60)
Zofran Multiple Myeloma	Fate Therapeutics	P3	B (60)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Multiple Myeloma	Indapta Therapeutics, INC.	P2	B (60)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Multiple Myeloma	Sanofi	P3	B (59)
FENTANYL Multiple Myeloma	Sanofi	P3	B (59)
Nivolumab Multiple Myeloma	Wake Forest University Health Sciences	P3	B (59)
Rapamycin Multiple Myeloma	National Cancer Institute (NCI)	P3	B (59)
Dasatinib Multiple Myeloma	Centro de Atencion e Investigacion Medica	P4	B (58)
Loratadine Multiple Myeloma	Emory University	P4	B (58)
Zanubrutinib Multiple Myeloma	Anne Louise Tølbøll Sørensen	P4	B (58)
Arlocabtagene Autoleucel Multiple Myeloma	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	P3	B (58)
azd0120 Multiple Myeloma	AstraZeneca	P3	B (58)
Bendamustine Multiple Myeloma	Uppsala University	P3	B (58)
gr1803 Multiple Myeloma	Genrix (Shanghai) Biopharmaceutical Co., Ltd.	P3	B (58)
gsk2857916 Multiple Myeloma	GlaxoSmithKline	P3	B (58)
Jnj-79635322 Multiple Myeloma	Janssen Research & Development, LLC	P3	B (58)

Showing 51 to 75 of 344 assets

PreviousPage 3 of 14Next